Records containing: Hemophilia A

This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.

• CLINICAL_TRIALS study record update · 2017-05-30
  A Multicenter, Non-Interventional Study Evaluating Bleeding Incidence, Health-Related Quality of Life, and Safety in Patients With Hemophilia A Under Standard-of-Care Treatment
• CLINICAL_TRIALS study record update · 2017-05-19
  Antihemophilic Factor (Recombinant) Plasma/Albumin-Free Method (rAHF PFM): A Phase 3/4, Prospective, Controlled, Randomized, Multi-Center Study to Compare the Efficacy and Safety of Continuous Infusion (CI) Versus Intermittent Bolus Infusion (BI) in Subjects With Severe or Moderately Severe Hemophilia A Undergoing Major Orthopedic Surgery
• CLINICAL_TRIALS study record update · 2017-04-26
  Inhibitor Development in Patients With Hemophilia A Undergoing Surgery
• CLINICAL_TRIALS study record update · 2017-04-07
  Inhibitor Development in Previously Untreated Patients (PUPs) or Minimally Blood Component-Treated Patients (MBCTPs) When Exposed to Plasma-derived Von Willebrand Factor-Containing Factor VIII (VWF/FVIII) Concentrates and to Recombinant Factor VIII (rFVIII) Concentrates: An Independent, International, Multicentre, Prospective, Controlled, Randomised, Open Label, Clinical Trial
• CLINICAL_TRIALS study record update · 2017-04-06
  An Ascending Single Dose Study To Evaluate The Safety, Tolerability And Pharmacokinetics/Pharmacodynamics Of Pf-05280602, A Recombinant Factor Viia Variant (813d), In Adult Hemophilia A And B Subjects With Or Without Inhibitors
• Organize your saved records without ads with Plus.
• CLINICAL_TRIALS study record update · 2017-04-04
  An Open-label, Single-arm, Post- Authorization Pragmatic Clinical Trial On The Safety And Efficacy Of Xyntha (Moroctocog-alfa (Af-cc), Recombinant Fviii) In Subjects With Hemophilia A In Usual Care Settings In China
• CLINICAL_TRIALS study record update · 2017-02-23
  Protected by Nature: Could Physical Activity Help to Counteract the Blood Haemophilia Disturbance? A Pilot Study.
• CLINICAL_TRIALS study record update · 2017-02-10
  A Prospective, Phase II/III Randomized, Mult-institutional Controlled, Open-label, Phase II Trial of Rituximab Versus Oral Cyclophosphamide to Eradicate or Suppress Autoimmune Anti-Factor VIII Antibodies in Patients With Acquired Hemophilia A
• CLINICAL_TRIALS study record update · 2017-02-03
  Phenotypic Heterogeneity in Hemophilia A: An Investigation of the Role of Platelet Function
• CLINICAL_TRIALS study record update · 2017-02-01
  Pharmacokinetic (PK) Analysis of a Novel Immunoassay in Hemophilia A
• CLINICAL_TRIALS study record update · 2016-12-21
  A Non-randomized, Open-label Study To Evaluate The Pharmacokinetics, Safety And Efficacy Of Refacto Af In Previously Treated Pediatric Subjects Less Than Twelve Years Of Age With Severe Hemophilia A (Fviii:c <1%).
• CLINICAL_TRIALS study record update · 2016-12-14
  An Institutional Pilot Study to Investigate Physical Activity Patterns in Boys With Hemophilia
• CLINICAL_TRIALS study record update · 2016-12-05
  A Phase 3 Prospective, Uncontrolled, Multicenter Study Evaluating Pharmacokinetics, Efficacy, Safety, and Immunogenicity of BAX 855 (PEGylated Full-length Recombinant FVIII) in Previously Treated Pediatric Patients With Severe Hemophilia A
• CLINICAL_TRIALS study record update · 2016-10-25
  A PHASE 3, PROSPECTIVE, OPEN-LABEL, RANDOMIZED STUDY TO EVALUATE SAFETY AND EFFICACY OF RECOMBINANT ACTIVATED FVII BI (rFVIIa BI) IN THE TREATMENT OF ACUTE BLEEDING EPISODES PER AN ON-DEMAND REGIMEN IN PATIENTS WITH HEMOPHILIA A OR B WITH INHIBITORS
• CLINICAL_TRIALS study record update · 2016-10-12
  An Open-Label, Multicenter Evaluation of Safety, Pharmacokinetics, and Efficacy of rFVIII in the Prevention and Treatment of Bleeding Episodes in Chinese With Hemophilia A
• CLINICAL_TRIALS study record update · 2016-10-03
  A Multi-center, Phase III, Non-controlled, Open-label Trial to Evaluate the Safety and Efficacy of SCT800 for On-demand Treatment in Previously Treated Patients With Hemophilia A
• CLINICAL_TRIALS study record update · 2016-09-26
  Hepatitis C in Clinically Discordant Hemophilic Siblings
• CLINICAL_TRIALS study record update · 2016-09-22
  ClinicalTrials.gov study NCT02911233
• CLINICAL_TRIALS study record update · 2016-09-07
  A Phase 2/3, Multi-Center, Open Label Study of Efficacy, Safety, and Pharmacokinetics of PEGylated Recombinant Factor VIII (BAX 855) Administered for Prophylaxis and Treatment of Bleeding in Previously Treated Patients With Severe Hemophilia A
• CLINICAL_TRIALS study record update · 2016-09-02
  Pharmacokinetic Comparison of SCT800 (B-domain Deleted Recombinant Factor VIII) With Xyntha in Previously Treated Patients With Hemophilia A: a Phase I, Open-label, Randomized, Crossover Study
• CLINICAL_TRIALS study record update · 2016-08-31
  GLOBAL HEMOSTATIC METHODS IN HEMOPHILIA AND VON WILLEBRAND'S DISEASE CORRELATION WITH PATIENTS' CLINICAL STATUS AND USEFULNESS FOR TREATMENT MONITORING
• CLINICAL_TRIALS study record update · 2016-08-17
  Personalized Prophylactic Treatment With Advate® in Severe or Moderate Haemophilia A Patients
• CLINICAL_TRIALS study record update · 2016-08-09
  A Phase I/III Open-label, Multicenter, Crossover Safety, Efficacy and Pharmacokinetic Study of Recombinant Coagulation Factor VIII (rFVIII) Compared to Recombinant Human Antihaemophilic Factor VIII (rFVIII; INN: Octocog Alfa) in Subjects With Hemophilia A, and a Repeat PK, Safety and Efficacy Study
• CLINICAL_TRIALS study record update · 2016-08-03
  Socialization of Adult Men With Congenital Hemophilia A or B: A Study to Examine Socialization Measures, the Role of Spouse/Significant Other and Health Related Quality of Life
• CLINICAL_TRIALS study record update · 2016-06-15
  An Open-label, Single Dose Pharmacokinetic Study Of Xyntha (Moroctocog Alfa (Af-cc), Recombinant Factor Viii) In Male Chinese Subjects With Hemophilia A